The Bogus CBD Side Effects that the FDA is Warning Us About are Absent from Epidiolex Labels

To everyone hoping, praying, or wishing for the federal government of the United States of America to “legalize weed” nationwide listen here and listen good: Be careful what you hope/pray/wish for, you just might get it.

When the Republican Senate Majority Leader Mitch McConnell handed the Republican President Donald Trump a pen made out of hemp to sign the 2018 Farm Bill, the two of them and most Americans thought that they had just ended decades of prohibition by legally defining “hemp” and removing that definition from the Controlled Substances Act. But that very definition is based purely on cannabinoid content – specifically THC which cannot exceed 0.3% - and somehow they neglected to consider the equally, if not more, popular healing cannabinoid of CBD which has no capped limit in legal hemp and was clearly the driving force behind the mainstream acceptance of the hemp plant.

To this day, the federal Food and Drug Administration has yet to issue concrete guidelines or regulations regarding crucial questions about manufacturing certain CBD-rich products and transporting them commercially from state to state. It almost feels like the Feds had never heard the term CBD before December of last year when they passed the Farm Bill, but we know that isn’t true because the FDA has granted approval for one – and only one – company to sell cannabis-derived CBD medication in the U.S. medical marketplace.

Epidiolex is the controversial tincture-like medication from UK-based GW Pharmaceuticals whose main active ingredient is CBD. The FDA-approved medication is targeted at treating intractable epilepsy (seizures), especially in young patients. It comes with a $32,000+ price tag which most parents would gladly pay to see their child’s suffering be alleviated, but we all know that similar if not better cannabis-based medicines are being bootlegged in kitchens across America for a fraction of that cost.

The process to become FDA-approved is very long and very costly. Now, it seems that the agency is digging its heels in to protect the monopoly that they and Epidiolex have on such a useful medication by putting out a warning about hemp-derived CBD use that makes this writer fear for how they may eventually treat cannabis legalization.

In a release issued Monday, December 2nd, 2019, the FDA warned that CBD “has the potential to harm you, and harm can happen even before you become aware of it.”

Well damn, why’d you legalize it then, dummies?

“We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,’” Amy Abernethy, the FDA’s principal deputy commissioner, said in the statement.

Ahhh, there it is. It’s not safe unless they’ve been paid off to say it’s safe.

Their gloomy statement warns that CBD could cause liver damage and can affect the male reproductive system – our balls, yo.

Scary, right?

Though it has surely helped many ailing kids, Epidiolex, the FDA-approved version of CBD, has been plagued by negative feedback from several parents who have forked over tens of thousands of dollars only to see lackluster results or even a worsening condition. The listed side-effects of Epidiolex are as follows:

· drowsiness,

· decreased appetite,

· diarrhea,

· transaminase elevations,

· fatigue,

· feeling unwell (malaise),

· weakness/lethargy,

· rash,

· difficulty sleeping (insomnia, disordered sleep, and poor quality sleep), and

· infections

Hmm, no liver damage warnings? No testicular nightmares? But, it's supposedly CBD and the FDA is telling us that CBD is bad, right?

It is estimated that no less than 64 million Americans have experimented with various forms of CBD at some point in the past two years. One out of every seven of them has made it a part of their daily wellness regimen. Meanwhile, the FDA is dragging its ass on the matter and refusing to issue clear regulations regarding this supposedly dangerous cannabinoid. Instead, they just boasted about sending out 15 sternly worded letters to CBD companies that they felt were pushing the boundaries of legal advertising of non-FDA-approved goods.

Just 15? Dude, my local health food store probably has 15 suspect brands of CBD products on the shelf right now.

This inaction from the federal government is the real danger. Not because they aren’t sending enough letters to enough CBD pushers, but because they are now casting an unsubstantiated shadow of doubt over what has become an increasingly popular and effective alternative to traditional pharmaceutical options chock full of unhealthy side effects like actually fucking with your liver or mutating your nutsack.

So, yeah, you’ll have to forgive me if I am not all too eager to hand over decades of hard fought battles for the legitimization of the cannabis plant just to hand it over to someone like Mitch McConnell or the hacks at the FDA to start defining and regulating.

In an ideal world the feds would just erase cannabis from the Controlled Substances Act and walk away without touching it further but, let’s face it, we’ve never lived in an ideal world. Still we’ll continue to fight.

73 views1 comment